United States-based MCI Diagnostic Center, a Service-Disabled Veteran-Owned small business that provides national laboratory testing and diagnostics in all 50 states, has launched a new laboratory in Dallas, Texas, it was reported on Friday.
The company is an SBA HUBZone certified and accredited by CLIA, CAP, COLA and FDA.
At the laboratory's official opening, Colleen Payne-Nabors MCI Diagnostic Center COO, said, 'We are providing a wonderful service in this time of need for our country. I thank each of you for coming and supporting the grand opening of MCI and we look forward to a long and healthy relationship on the other side of COVID-19.'
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval